Riskpilot← Back to searchSign inGet full accessGLYCOM A/S
A/SActiveCVR 28512457Kogle Alle 4Research and experimental development on natural sciences and engineering · NACE 7210Est. 200551 employees
Revenue 2024
DKK 170,4M
+11% vs 2023
EBITDA margin
73.8%
+18% vs 2023
Equity ratio
84.8%
Financial strength
Net profit 2024
DKK 72M
+41% vs 2023
| Revenue | DKK 170,4M | +11% |
| EBITDA | DKK 125,7M | +18% |
| Net profit | DKK 72M | +41% |
| Total assets | DKK 667,8M | -28% |
| Equity | DKK 566,4M | +15% |
| Employees | 51 | — |
Legal name
GLYCOM A/S
CVR number
28512457
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22. marts 2005
Share capital
DKK 1.789.867
Employees
51 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller af 1 bestyrelsesmedlem og 1 direktør i forening.
Company purpose
Selskabets formål er at drive virksomhed inden for udvikling af og handel med nye biomolekyler til den farmaceutiske industri og ernæringsindustrien.
Address
Kogle Alle 4
Phone
+4588309500
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 601 | -47.123 | 6.248 | — | — | — | 134.598 | 210.965 | 123.707 | 204.626 | 170.758 | 154.033 | 170.387 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -27.624 | -31.581 | -16.999 | -17.950 | -0 | -0 | -36.251 | -40.997 | -53.384 | -52.010 | -36.765 | -47.905 | -44.704 |
| EBITDA | — | — | — | — | — | — | — | -27.023 | -78.704 | -10.751 | -19.183 | 0 | 0 | 76.588 | 99.538 | 66.985 | 122.544 | 133.994 | 106.128 | 125.683 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1.474 | -2.906 | -2.935 | -3.858 | -0 | -0 | -13.441 | -14.136 | -21.790 | -25.597 | -27.803 | -26.573 | -24.186 |
| EBIT | — | — | — | — | — | — | — | -28.497 | -81.610 | -13.686 | -23.041 | 0 | 0 | 63.147 | 85.402 | 45.195 | 96.947 | 106.191 | 79.555 | 101.497 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.657 | -872 | -534 | -6.201 | 0 | 0 | -65.261 | -32.104 | -48.565 | -4.240 | -4.476 | -13.157 | -9.137 |
| Profit before tax | — | — | — | — | — | — | — | -26.840 | -82.482 | -14.220 | -29.242 | 0 | 0 | -2.114 | 53.297 | 17.484 | 92.707 | 101.714 | 66.398 | 92.360 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -979 | -3.270 | -3.686 | -27.112 | -0 | -0 | 12.042 | 22.763 | 6.879 | 19.886 | 21.688 | 15.346 | 20.319 |
| Net profit | — | — | — | — | — | — | — | -25.861 | -79.212 | -10.534 | -2.130 | 0 | 0 | -14.156 | 30.534 | 10.605 | 72.821 | 80.026 | 51.052 | 72.041 |
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 138.252 | 66.543 | 101.998 | 161.951 | 4.345 | 171.683 | 722.910 | 761.630 | 730.001 | 747.724 | 880.539 | 931.111 | 667.790 |
| Equity | — | — | — | — | — | — | — | 125.706 | 46.391 | 36.462 | 45.792 | 1.384 | 1.482 | 30.433 | 217.798 | 270.893 | 343.714 | 423.740 | 494.349 | 566.390 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95 | 0 | 45.644 | 93.407 | 205.123 | 434.262 | 540.780 | 24.640 | 10.210 | 13.625 | 2.389 | 4.663 | 1.754 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.451 | 20.152 | 19.892 | 22.752 | 0 | 0 | 151.697 | 519.192 | 448.898 | 375.166 | 430.781 | 396.983 | 64.530 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.546 | 20.152 | 65.536 | 116.159 | 205.123 | 434.262 | 692.477 | 543.832 | 459.108 | 388.791 | 433.170 | 401.646 | 66.284 |
EBITDA margin
73.8%
This company
15.8%
Market median
+367% vs market
20052024
Equity ratio
84.8%
This company
38.2%
Market median
+122% vs market
20052024
Return on equity
12.7%
This company
18.4%
Market median
+31% vs market
20052024
Net profit margin
42.3%
This company
8.1%
Market median
+422% vs market
20052024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20052024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20052024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via CVR / Virk · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via CVR / Virk · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via CVR / Virk · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via CVR / Virk · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via CVR / Virk · Period 2007-01-01 – 2007-12-31
- Annual report 2006Filed via CVR / Virk · Period 2006-01-01 – 2006-12-31
- Annual report 2005Filed via CVR / Virk · Period 2005-03-22 – 2005-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IL Management | Management | 2005 | — | — |
LH Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
OE Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
FK Chief Executive Officer | Chief Executive Officer | 2007 | — | — |
JM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
AM Deputy | Deputy | 2006 | — | — |
JY Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2006 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2005 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2005 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DSM Nutritional Products Denmark ApS | Company | 100.0% | 100.0% | 2020 |
DANICA PENSION, LIVSFORSIKRINGSAKTIESELSKAB | Company | 10.0% | 10.0% | 2019 |
| Individual | 5.0% | 5.0% | 2019 | |
| Individual | 5.0% | 5.0% | 2019 | |
| Individual | 0.0% | 0.0% | 1903 | |
| Individual | 5.0% | 5.0% | 2015 | |
| Individual | 33.3% | 33.3% | 2011 | |
Anpartsselskabet af 30. september 2015 nr. 2 | Company | 0.0% | 0.0% | 1903 |
ZIRA INVEST II ApS | Company | 0.0% | 0.0% | 1903 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DSM Nutritional Products Denmark ApS
GLYCOM A/S Board members of GLYCOM A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inge Lundt | Management | 0 companies |
| Leif Helth Jensen | Chief Executive Officer | 0 companies |
| Odd Erik Hansen | Chief Executive Officer | 0 companies |
| Frank Knudsen | Chief Executive Officer | 0 companies |
| Jesper Mørk | Chief Executive Officer | 0 companies |
| Anders Myssen Hoen | Deputy | 0 companies |
| James Young | Chief Executive Officer | 0 companies |
| Joachim Erich Thiem | Board of Directors | 0 companies |
| Gareth Allan Barker | Chairman | 0 companies |
| Peter Høngård Andersen | Chairman | 0 companies |
| Heiko Willem-Jan Schipper | Board of Directors | 0 companies |
| Peter Michael Rothschild | Board of Directors | 0 companies |
| Maha Mazhar Ali Abdelhamid Elkharbotly | Chairman | 0 companies |
| Francois Scheffler | Board of Directors | 0 companies |
| Thomas Franz Schweizer | Board of Directors | 0 companies |
| Harold Vincent Christophe Humbert | Board of Directors | 0 companies |
| Jes Christian Wibroe Østergaard | Chairman | 0 companies |
| Gyula Dekany | Board of Directors | 0 companies |
| Thierry Marie Philardeau | Board of Directors | 0 companies |
| Michel Roger Bernard Gardet | Board of Directors | 0 companies |
| Niels Axel Stokholm Banke | Board of Directors | 0 companies |
| Behrend Friedrich Lundt | Board of Directors | 0 companies |
| Malcolm Bruce Hunter | Board of Directors | 0 companies |
| Ole Lund Svendsen | Board of Directors | 0 companies |
| Sten Verland | Board of Directors | 0 companies |
| Christian Kanstrup | Board of Directors | 0 companies |
| Anders Glargaard | Board of Directors | 0 companies |
| Kjeld Raunkjær Kjeldsen | Chairman | 0 companies |